Vascular calcification (VC) is a hallmark feature of cardiovascular disease and a significant risk factor for morbidity and mortality. Salusin-β exerts cardiovascular regulating effects in hypertension, atherosclerosis, and diabetes. The present study was designed to examine the roles of salusin-β in the progression of VC and its downstream signaling mechanisms.
Results:
Salusin-β expression in both the aortas of VC rats induced by vitamin D3 and nicotine and vascular smooth muscle cells (VSMCs) incubated with calcifying media was increased. Salusin-β knockdown remarkably reduced VC, whereas overexpression of salusin-β exacerbated VC both in vitro and in vivo. Overexpression of salusin-β promoted the VSMC osteochondrogenic transition, decreased Klotho protein levels, enhanced Ras-related C3 botulinum toxin substrate 1 (Rac1) activity and the translocation of p47phox to the membrane, increased the expression of nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase subunits and the production of reactive oxygen species (ROS) with or without calcifying media; however, salusin-β deficiency played the opposite roles. The calcification and downregulated Klotho protein levels induced by salusin-β were restored by ROS scavenger N-acetyl-l-cysteine, diphenyleneiodonium chloride [an inhibitor of flavin-containing enzyme, including NAD(P)H oxidase], or gene knockdown of NAD(P)H oxidase (NOX)-2, p22phox, or p47phox but were not affected by NOX-1 and NOX-4 knockdown. Klotho knockdown attenuated the protective effect of salusin-β deficiency on VSMC calcification. By contrast, exogenous Klotho ameliorated the development of VC and ROS generation induced by salusin-β overexpression.
Innovation:
Salusin-β is a critical modulator in VC.
Conclusion:
Salusin-β regulates VC through activation of NAD(P)H/ROS-mediated Klotho downregulation, suggesting that salusin-β may be a novel target for treatment of VC.
Get full access to this article
View all access options for this article.
References
1.
AcevedoA and Gonzalez-BillaultC. Crosstalk between Rac1-mediated actin regulation and ROS production. Free Radic Biol Med, 116: 101–113, 2018.
2.
BedardK and KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87: 245–313, 2007.
3.
BessueilleL and MagneD. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes. Cell Mol Life Sci, 72: 2475–2489, 2015.
4.
BrietM and BurnsKD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond), 123: 399–416, 2012.
5.
ChangJR, GuoJ, WangY, HouYL, LuWW, ZhangJS, YuYR, XuMJ, LiuXY, WangXJ, GuanYF, ZhuY, DuJ, TangCS, and QiYF. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of alpha-Klotho. Kidney Int, 89: 586–600, 2016.
6.
ChistiakovDA and MyasoedovaVA. Calcifying matrix vesicles and atherosclerosis. Biomed Res Int, 2017: 7463590, 2017.
7.
DuanXH, ChangJR, ZhangJ, ZhangBH, LiYL, TengX, ZhuY, DuJ, TangCS, and QiYF. Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification. Apoptosis, 18: 1132–1144, 2013.
8.
FujimotoK, HayashiA, KamataY, OgawaA, WatanabeT, IchikawaR, IsoY, KobaS, KobayashiY, KoyamaT, and ShichiriM. Circulating levels of human salusin-beta, a potent hemodynamic and atherogenesis regulator. PLoS One, 8: e76714, 2013.
9.
GeisztM. NADPH oxidases: new kids on the block. Cardiovasc Res, 71: 289–299, 2006.
GuoY, ZhuangX, HuangZ, ZouJ, YangD, HuX, DuZ, WangL, and LiaoX. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-kappaB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis, 1864: 238–251, 2018.
12.
HawkinsCL. Protein carbamylation: a key driver of vascular calcification during chronic kidney disease. Kidney Int, 94: 12–14, 2018.
13.
HilenskiLL, ClempusRE, QuinnMT, LambethJD, and GriendlingKK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 24: 677–683, 2004.
14.
HoE, Karimi GalougahiK, LiuCC, BhindiR, and FigtreeGA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol, 1: 483–491, 2013.
15.
HuMC, Kuro-oM, and MoeOW. alphaKlotho and vascular calcification: an evolving paradigm. Curr Opin Nephrol Hypertens, 23: 331–339, 2014.
16.
HuMC, ShiM, ZhangJ, QuinonesH, GriffithC, Kuro-oM, and MoeOW. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol, 22: 124–136, 2011.
LeemJ and LeeIK. Mechanisms of vascular calcification: the pivotal role of pyruvate dehydrogenase kinase 4. Endocrinol Metab (Seoul), 31: 52–61, 2016.
23.
LiH, TengX, YangR, GuoQ, XueH, XiaoL, DuanX, TianD, FengX, and WuY. Hydrogen sulfide facilitates the impaired sensitivity of carotid sinus baroreflex in rats with vascular calcification. Front Pharmacol, 8: 629, 2017.
24.
LimK, LuTS, MolostvovG, LeeC, LamFT, ZehnderD, and HsiaoLL. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation, 125: 2243–2255, 2012.
25.
LiuL, LiuY, ZhangY, BiX, NieL, LiuC, XiongJ, HeT, XuX, YuY, YangK, GuJ, HuangY, ZhangJ, ZhangZ, ZhangB, and ZhaoJ. High phosphate-induced downregulation of PPARgamma contributes to CKD-associated vascular calcification. J Mol Cell Cardiol, 114: 264–275, 2018.
26.
LiuQF, YeJM, YuLX, DongXH, FengJH, XiongY, GuXX, and LiSS. Klotho mitigates cyclosporine A (CsA)-induced epithelial-mesenchymal transition (EMT) and renal fibrosis in rats. Int Urol Nephrol, 49: 345–352, 2017.
27.
LiuY, LinF, FuY, ChenW, LiuW, ChiJ, ZhangX, and YinX. Cortistatin inhibits arterial calcification in rats via GSK3beta/beta-catenin and protein kinase C signalling but not c-Jun N-terminal kinase signalling. Acta Physiol (Oxf), 223: e13055, 2018.
LiuYN and ZhouJ. Sulodexide protects renal tubular epithelial cells from oxidative stress-induced injury via upregulating klotho expression at an early stage of diabetic kidney disease. J Diabetes Res, 2017: 4989847, 2017.
30.
MaYY, SunL, ChenXJ, WangN, YiPF, SongM, ZhangB, WangYZ, and LiangQH. Vinpocetine attenuates the osteoblastic differentiation of vascular smooth muscle cells. PLoS One, 11: e0162295, 2016.
31.
MazziniMJ and SchulzePC. Proatherogenic pathways leading to vascular calcification. Eur J Radiol, 57: 384–389, 2006.
32.
MenckeR and HillebrandsJL. The role of the anti-ageing protein klotho in vascular physiology and pathophysiology. Ageing Res Rev, 35: 124–146, 2017.
33.
MitobeM, YoshidaT, SugiuraH, ShirotaS, TsuchiyaK, and NiheiH. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol, 101: e67–e74, 2005.
34.
NagashimaM, WatanabeT, ShiraishiY, MoritaR, TerasakiM, AritaS, HongoS, SatoK, ShichiriM, MiyazakiA, and HiranoT. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis, 212: 70–77, 2010.
35.
National Research Council; Division on Earth and Life Studies; Institute for Laboratory Animal Research; Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press, 2011, p. 246.
36.
RavikumarP, YeJ, ZhangJ, PinchSN, HuMC, Kuro-oM, HsiaCC, and MoeOW. alpha-Klotho protects against oxidative damage in pulmonary epithelia. Am J Physiol Lung Cell Mol Physiol, 307: L566–L575, 2014.
37.
RenXS, LingL, ZhouB, HanY, ZhouYB, ChenQ, LiYH, KangYM, and ZhuGQ. Silencing salusin-beta attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats. Sci Rep, 7: 43259, 2017.
38.
RogersMA and AikawaE. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat Rev Cardiol, 16: 261–274, 2019.
39.
ShanahanCM. Inflammation ushers in calcification: a cycle of damage and protection?. Circulation, 116: 2782–2785, 2007.
40.
ShaoJS, CaiJ, and TowlerDA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol, 26: 1423–1430, 2006.
41.
ShichiriM, IshimaruS, OtaT, NishikawaT, IsogaiT, and HirataY. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med, 9: 1166–1172, 2003.
42.
ShimamuraY, HamadaK, InoueK, OgataK, IshiharaM, KagawaT, InoueM, FujimotoS, IkebeM, YuasaK, YamanakaS, SugiuraT, and TeradaY. Serum levels of soluble secreted alpha-klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol, 16: 722–729, 2012.
43.
ShioiA. Vascular calcification—pathological mechanism and clinical application—mechanisms of vascular calcification [in Japanese]. Clin Calcium, 25: 635–643, 2015.
44.
SunH, ZhuX, LinW, ZhouY, CaiW, and QiuL. Interactions of TLR4 and PPARgamma, dependent on AMPK signalling pathway contribute to anti-inflammatory effects of vaccariae hypaphorine in endothelial cells. Cell Physiol Biochem, 42: 1227–1239, 2017.
45.
SunHJ, ChenD, WangPY, WanMY, ZhangCX, ZhangZX, LinW, and ZhangF. Salusin-beta is involved in diabetes mellitus-induced endothelial dysfunction via degradation of peroxisome proliferator-activated receptor gamma. Oxid Med Cell Longev, 2017: 6905217, 2017.
46.
SunHJ, LiuTY, ZhangF, XiongXQ, WangJJ, ChenQ, LiYH, KangYM, ZhouYB, HanY, GaoXY, and ZhuGQ. Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta, 1852: 1709–1718, 2015.
47.
SunHJ, RenXS, XiongXQ, ChenYZ, ZhaoMX, WangJJ, ZhouYB, HanY, ChenQ, LiYH, KangYM, and ZhuGQ. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis, 8: e3074, 2017.
48.
SunHJ, ZhangLL, FanZD, ChenD, ZhangL, GaoXY, KangYM, and ZhuGQ. Superoxide anions involved in sympathoexcitation and pressor effects of salusin-beta in paraventricular nucleus in hypertensive rats. Acta Physiol (Oxf), 210: 534–545, 2014.
49.
SunHJ, ZhaoMX, LiuTY, RenXS, ChenQ, LiYH, KangYM, and ZhuGQ. Salusin-beta induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFkappaB pathway. Sci Rep, 6: 23596, 2016.
50.
SunHJ, ZhaoMX, RenXS, LiuTY, ChenQ, LiYH, KangYM, WangJJ, and ZhuGQ. Salusin-beta promotes vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via ROS/NFkappaB/MMP-9 pathway. Antioxid Redox Signal, 24: 1045–1057, 2016.
51.
SunHJ, ZhouH, FengXM, GaoQ, DingL, TangCS, ZhuGQ, and ZhouYB. Superoxide anions in the paraventricular nucleus mediate cardiac sympathetic afferent reflex in insulin resistance rats. Acta Physiol (Oxf), 212: 267–282, 2014.
52.
Ter BraakeAD, ShanahanCM, and de BaaijJHF. Magnesium counteracts vascular calcification: passive interference or active modulation?. Arterioscler Thromb Vasc Biol, 37: 1431–1445, 2017.
53.
ThurstonRD, LarmonierCB, MajewskiPM, RamalingamR, Midura-KielaM, LaubitzD, VandewalleA, BesselsenDG, MuhlbauerM, JobinC, KielaPR, and GhishanFK. Tumor necrosis factor and interferon-gamma down-regulate klotho in mice with colitis. Gastroenterology, 138: 1384–1394, 1394.e1–1394.e2, 2010.
54.
TowlerDA and DemerLL. Thematic series on the pathobiology of vascular calcification: an introduction. Circ Res, 108: 1378–1380, 2011.
55.
van der ZeeS, BaberU, ElmariahS, WinstonJ, and FusterV. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol, 6: 580–589, 2009.
56.
WatanabeT, NishioK, KanomeT, MatsuyamaTA, KobaS, SakaiT, SatoK, HongoS, NoseK, OtaH, KobayashiY, KatagiriT, ShichiriM, and MiyazakiA. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation, 117: 638–648, 2008.
57.
WiniarskaK, DzikJM, LabuddaM, FochtD, SierakowskiB, OwczarekA, KomorowskiL, and BieleckiW. Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase. J Pineal Res, 60: 109–117, 2016.
YoonHE, GheeJY, PiaoS, SongJH, HanDH, KimS, OhashiN, KoboriH, Kuro-oM, and YangCW. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant, 26: 800–813, 2011.
60.
ZhangP, LiY, DuY, LiG, WangL, and ZhouF. Resveratrol ameliorated vascular calcification by regulating Sirt-1 and Nrf2. Transplant Proc, 48: 3378–3386, 2016.
ZhuX, ZhouZ, ZhangQ, CaiW, ZhouY, SunH, and QiuL. Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats. J Cell Biochem, 119: 926–937, 2018.
63.
ZhuY, TakayamaT, WangB, KentA, ZhangM, BinderBY, UrabeG, ShiY, DiRenzoD, GoelSA, ZhouY, LittleC, RoenneburgDA, ShiXD, LiL, MurphyWL, KentKC, KeJ, and GuoLW. Restenosis inhibition and re-differentiation of TGFbeta/Smad3-activated smooth muscle cells by resveratrol. Sci Rep, 7: 41916, 2017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
